Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

Abbott

First CVE: Feb 13, 2017Active for: 9 yearsTotal CVEs: 6

Abbott's vulnerability profile centers on its Accent line of cardiac implantable electronic devices (CIEDs) and related firmware, a specialized medical-device portfolio with limited breadth but significant clinical implications. The recurring exposure involves wireless-communication and authentication weaknesses—cleartext transmission of sensitive information, improper authentication, and missing encryption—that reflect the constraints of implanted-device design and the tension between functionality, power consumption, and security. Current severity, exploitation activity, and exposure counts are shown alongside this summary.

FAUCET AI Generated
6
Total CVEs
More Total CVEs than 86% of tracked vendors
0.1
Avg CVEs / Product / Year
More Avg CVEs / Product / Year than 1% of tracked vendors
7.5
Avg CVSS Score
Higher Avg CVSS Score than 56% of tracked vendors
0.0%
In CISA KEV
Bottom 1%

Trends Over Time

The number and severity of CVEs published that impact products developed by Abbott over time

Volume of CVEsAvg CVSS Base Score
First CVE
Feb 13, 2017
9 years ago
Most Recent CVE
Nov 14, 2023
983 days ago

Products(21 total)

Top CVEs

Signals from CVEs in this vendor scope (6 CVEs).

6 CVEs · Highest risk first

CVEPublishedCVSSRiskKEVExploit
CVE-2017-12712HIGH
The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypass
Apr 25, 20188.828NONO
CVE-2020-8997HIGH
Older generation Abbott FreeStyle Libre sensors allow remote attackers within close proximity to enable write access to memory via a specific NFC unlock command. NOTE: The vulnerab
Feb 16, 20208.827NONO
CVE-2017-5149HIGH
An issue was discovered in St. Jude Medical Merlin@home, versions prior to Version 8.2.2 (RF models: EX1150; Inductive models: EX1100; and Inductive models: EX1100 with MerlinOnDem
Feb 13, 20178.927NONO
CVE-2017-12716MEDIUM
Abbott Laboratories Accent and Anthem pacemakers manufactured prior to Aug 28, 2017 transmit unencrypted patient information via RF communications to programmers and home monitorin
Apr 25, 20186.520NONO
CVE-2023-47262MEDIUM
The startup process and device configurations of the Abbott ID NOW device, before v7.1, can be interrupted and/or modified via physical access to an internal serial port. Direct ph
Nov 14, 20235.217NONO
CVE-2017-12714MEDIUM
Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may a
Apr 25, 20186.517NONO
View all 6 CVEs →

CVE Severity & Scoring

Severity distribution of CVEs that affect this vendor's products6 CVEs
50%
50%
Severity distribution among all CVEs352,231 CVEs
45%
40%
11%
MediumHigh
Attack Vector
Local0 (0.0%)
Network1 (16.7%)
Unknown0 (0.0%)
Physical1 (16.7%)
Adjacent Network4 (66.7%)
Attack Complexity
Low5 (83.3%)
High1 (16.7%)
Unknown0 (0.0%)
User Interaction
None6 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None6 (100.0%)
Unknown0 (0.0%)

Exploit Exposure

Signals from CVEs in this vendor scope (6 CVEs).

CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%

Social Chatter

An overview of all social media posts that mention a CVE ID that affects a product developed by Abbott.

Media Mentions

Media articles that mention a CVE ID that affects a product developed by Abbott — matched by CVE ID, not by vendor name.

Top CNAs Publishing CVEs For Abbott's Products

View all 2 CNAs →

Top CWEs